Worth your time
The White House says drug prices are falling. But the index they used for this new report does not account for all medicines, including some newer and pricier drugs, STAT reports. — Erin MershonPharmaceutical companies are exploiting a gray area in U.S. immigration law and using payments as small as $20 to lure Mexican citizens across the border to donate their blood plasma, ProPublica reports, often putting their health at risk. — Lev Facher
Nevada's going to fine drug companies more than $17 million for failing to supply information required by a controversial state law. STAT's got the story. — Erin Mershon
The New York Times has a great rundown of the controversy surrounding the FDA’s approval of Descovy, the new PrEP drug from Gilead. — Nick Florko
No hay comentarios:
Publicar un comentario